Arkuda Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Arkuda Therapeutics's estimated annual revenue is currently $7.1M per year.
- Arkuda Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Arkuda Therapeutics has 46 Employees.
- Arkuda Therapeutics grew their employee count by -16% last year.
Arkuda Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Head Clinical Development | Reveal Email/Phone |
3 | SVP, Head Discovery | Reveal Email/Phone |
4 | VP, Medicinal Chemistry | Reveal Email/Phone |
5 | VP, Finance | Reveal Email/Phone |
6 | Director, Medicinal Chemistry | Reveal Email/Phone |
7 | Senior Director Human Resources | Reveal Email/Phone |
8 | Associate Director, Toxicology | Reveal Email/Phone |
9 | Chief Business Officer | Reveal Email/Phone |
10 | Staff Scientist | Reveal Email/Phone |
Arkuda Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Arkuda Therapeutics?
Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease.
keywords:N/A
N/A
Total Funding
46
Number of Employees
$7.1M
Revenue (est)
-16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Arkuda Therapeutics News
2022-02-22 - Arkuda Reels in Another $64M to Disrupt Neurodegenerative ...
The company is developing therapeutic compounds that treat neurodegenerative diseases in which genetically linked biological dysfunction of a...
2022-02-22 - Arkuda Therapeutics Raises $64 Million Series B Financing to ...
Arkuda Therapeutics is a biotechnology company applying insights into lysosomal and microglial biology to drive the development of medicines to...
2022-02-22 - Arkuda Therapeutics Raises $64M in Series B Financing
Arkuda Therapeutics, a Watertown MA-based biotechnology company, raised $64M in Series B funding. The round was led by Cormorant Asset...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 46 | -12% | N/A |
#2 | $6.6M | 46 | -8% | N/A |
#3 | $3.8M | 46 | N/A | N/A |
#4 | $5.3M | 46 | N/A | N/A |
#5 | $9.9M | 46 | 28% | N/A |